Jeena Sikho Lifecare Limited (JSLL) Earnings Call Transcript & Summary
November 7, 2025
Earnings Call Speaker Segments
Operator
operatorLadies and gentlemen, good day, and welcome to the Jeena Sikho Lifecare Limited Q2 FY '26 Earnings Conference Call. [Operator Instructions] Please note that this conference is being recorded. I now hand the conference over to Mr. Ranvir Singh from Nuvama Wealth. Thank you, and over to you, sir.
Ranvir Singh
analystOn behalf of Jeena Sikho Lifecare Limited, I extend a very warm welcome to all participants on the Q2 FY '26 financial results discussion call. Today on the call, we have Mr. Manish Grover ji, popularly known as Acharya ji, Managing Director; and Mr. Nanak Chand, CFO. Before beginning with this call, I would like to give a short disclaimer. This call may contain some of the forward-looking statements, which are completely based upon management's belief, opinion and expectations as of today. These statements are not a guarantee of company's future performance and involve unforeseen risks and uncertainties. With this, I would like to hand over the call to Acharya Manish ji for his opening remarks. Over to you, sir.
Manish Grover
executive[Foreign Language]
Nanak Chand
executiveGood afternoon, everyone. Thanks, Manish sir. As mentioned by Manish sir, we have achieved a healthy financial performance during the Q2 FY '26. Here are the key highlights. Q2 FY '26 results. So I am pleased to present before you the detailed financial performance of Jeena Sikho Lifecare Limited for quarter ended September 30, 2025, Q2 FY '26. Before we move to the details, I would like to highlight that it was the second quarter of reporting under Ind AS following our migration to main Board in August 2025. And our financial statements and disclosures are now fully aligned with the main Board standard and showing high transparency and compatibility. The company continues to maintain the strong balance sheet supported by the robust operating cash flows and prudent financial management. Now on the Q2 FY '26 performance. Revenue, our revenue grew by 66% on a Y-o-Y basis to INR 190 crores in Q2 FY '26 as product segment grew approximately 78% Y-o-Y. Service segment contributed 50% revenue during the quarter. The EBITDA during the Q2 FY '26 [ jumped over the ] 129% Y-o-Y basis to INR 92 crores by implying the EBITDA margins of 48%. The Q2 FY '26 PAT grew 121% Y-o-Y basis to INR 58.78 crores. With this, we open the floor for the question-and-answer session. Thank you.
Operator
operator[Operator Instructions] The first question is from the line of Akshay from AK Investment.
Manish Grover
executive[Foreign Language]
Akshay Kaila
analyst[Foreign Language]
Manish Grover
executive[Foreign Language]
Akshay Kaila
analyst[Foreign Language]
Manish Grover
executive[Foreign Language]
Akshay Kaila
analyst[Foreign Language]
Manish Grover
executive[Foreign Language]
Operator
operatorThe next question is from the line of Abhishek from AB Capital.
Unknown Analyst
analystAm I audible?
Manish Grover
executive[Foreign Language]
Unknown Analyst
analyst[Foreign Language]
Manish Grover
executive[Foreign Language]
Unknown Analyst
analyst[Foreign Language]
Manish Grover
executive[Foreign Language]
Operator
operatorThe next question is from the line of Ashok Parekh, an individual investor.
Manish Grover
executive[Foreign Language]
Unknown Attendee
attendee[Foreign Language]
Manish Grover
executive[Foreign Language]
Unknown Attendee
attendee[Foreign Language]
Manish Grover
executive[Foreign Language]
Unknown Attendee
attendee[Foreign Language]
Manish Grover
executive[Foreign Language]
Unknown Attendee
attendee[Foreign Language]
Manish Grover
executive[Foreign Language]
Operator
operator[Operator Instructions] The next question is from the line of Praveen Kumar, an individual investor.
Unknown Attendee
attendeeSir, can you hear me?
Manish Grover
executive[Foreign Language]
Unknown Attendee
attendee[Foreign Language] Manish ji, I was looking -- eagerly waiting to get in the call with you. Right. So many congratulations on your Q2 numbers. And I have a couple of questions, Manish ji. How is the early trend of your OTC business? First question. And my second question is, is there any revenue sharing planned with Chandan Healthcare? What's the strategy of planning there? And my last question is that do you want to update your FY '26 guidance from previously quoted INR 700 crores?
Manish Grover
executive[Foreign Language]
Unknown Attendee
attendeeOkay. Sir, I'm not that comfortable with Hindi, but I can understand. But I'm not -- I can't speak...
Manish Grover
executive[Foreign Language]
Nanak Chand
executiveAnd there was one more question on the guidance of '26. Would you like to update that?
Manish Grover
executive[Foreign Language]
Operator
operatorThe next question is from the line of Gaurav Sanghvi, an individual investor.
Unknown Attendee
attendeeAm I audible?
Manish Grover
executiveYes. [Foreign Language]
Unknown Attendee
attendee[Foreign Language]
Manish Grover
executive[Foreign Language]
Unknown Attendee
attendee[Foreign Language]
Manish Grover
executive[Foreign Language]
Operator
operatorThe next question is from the line of Sainik Mehta from [indiscernible] Wealth.
Unknown Analyst
analyst[Foreign Language]
Manish Grover
executive[Foreign Language]
Operator
operatorThe next question is from the line of Deepak Poddar from Sapphire Capital.
Deepak Poddar
analystAm I audible, sir?
Manish Grover
executiveYes, sir. [Foreign Language]
Deepak Poddar
analyst[Foreign Language]
Manish Grover
executive[Foreign Language]
Deepak Poddar
analyst[Foreign Language]
Manish Grover
executive[Foreign Language]
Deepak Poddar
analyst[Foreign Language]
Manish Grover
executive[Foreign Language]
Deepak Poddar
analystOkay. Okay. And just last final thing, [Foreign Language]
Manish Grover
executive[Foreign Language]
Operator
operatorThe next question is from the line of [ Pratik Tandale ] from Code Advisors LLP.
Unknown Analyst
analystHello, am I audible?
Manish Grover
executiveYes, sir.
Unknown Analyst
analyst[Foreign Language] Q1, we had 55. They stand at, right now?
Manish Grover
executiveNow, we have 58.
Unknown Analyst
analyst58. In terms of clinic, we had 61 as of Q1.
Manish Grover
executiveNow we have 59.
Unknown Analyst
analystRight. And the number of beds?
Manish Grover
executiveAnd 35 franchisees.
Unknown Analyst
analyst35 franchisees. Okay. We have bed...
Manish Grover
executive46, we have NABH centers now.
Unknown Analyst
analyst45 NABH. Okay.
Manish Grover
executive46 NABH. And 5 are in pipeline.
Unknown Analyst
analyst46, 5 in pipeline. In terms of IPD and OPD, if you could give the updated numbers for Q2.
Manish Grover
executiveSir, IPD 58 hospital [Foreign Language]
Unknown Analyst
analystNo, sir. I'm talking in terms of -- So Q1, we were at 861 -- 8,616, and OPD was 1.24 lakh. So...
Manish Grover
executive[Foreign Language]
Unknown Analyst
analyst[Foreign Language]
Manish Grover
executive8,616 first quarter, and 9,614 in second quarter. And total OPD volume is 1,24,364 in quarter 1. Now is 1,40,144 in quarter 2.
Unknown Analyst
analystOkay. Perfect. And net profit margin guidance is 20% to 22%, right?
Manish Grover
executiveYes, yes. Our average revenue per bed on quarter 1 is INR 8,287 and in quarter 2 is INR 8,324. Our occupancy is about same 57%.
Unknown Analyst
analyst57%. Similar as Q1, right?
Manish Grover
executiveSimilar as Q1. If we calculate from last financial year '25 bed, it is more than 80%. Because 1,600 bed total in [ 50 ] '25. [Foreign Language]
Unknown Analyst
analystNumber of beds as of Q1 was 2,179. Am I correct?
Manish Grover
executiveYes, yes. As of now is 2,220.
Unknown Analyst
analyst2,220. These are open 2,800. This is your remaining in 2 to 3 months [Foreign Language]
Manish Grover
executive[Foreign Language]
Unknown Analyst
analystRight. So the operational one as of this quarter is 22...
Manish Grover
executive2,220.
Operator
operatorThe next question is from the line of Ronak Duggar, an individual investor.
Unknown Attendee
attendee[Foreign Language]
Manish Grover
executive[Foreign Language]
Unknown Attendee
attendee[Foreign Language]
Manish Grover
executive[Foreign Language]
Unknown Attendee
attendee[Foreign Language]
Manish Grover
executive[Foreign Language]
Operator
operatorSorry to interrupt, Mr. Ronak. May we request you to please rejoin the queue. We have participants waiting for their turn. The next question is from the line of Amit Joshi, an individual investor.
Unknown Attendee
attendee[Foreign Language]
Manish Grover
executive[Foreign Language]
Unknown Attendee
attendee[Foreign Language] 985548... [Foreign Language]
Manish Grover
executive9855487770.
Unknown Analyst
analyst[Foreign Language]
Manish Grover
executive[Foreign Language]
Operator
operatorThe next question is from the line of Kamal Sharma from Srishti Wealth.
Unknown Attendee
attendee[Foreign Language]
Manish Grover
executive[Foreign Language]
Unknown Attendee
attendee[Foreign Language]
Manish Grover
executive[Foreign Language] Nanak ji?
Nanak Chand
executive[Foreign Language]
Manish Grover
executive[Foreign Language]
Operator
operatorThe next question is from the line of Devi Agrawal from [ Fimcom ] Family Office.
Unknown Attendee
attendee[Foreign Language]
Manish Grover
executiveNanak ji?
Nanak Chand
executiveFirst of all [Foreign Language]
Manish Grover
executive[Foreign Language]
Unknown Attendee
attendee[Foreign Language]
Manish Grover
executive[Foreign Language]
Unknown Attendee
attendee[Foreign Language] financial statement restate [Foreign Language]
Manish Grover
executive[Foreign Language] Nanak ji?
Nanak Chand
executiveYes, sir. Yes, yes. [Foreign Language] we'll share with you.
Operator
operatorThe next question is from the line of Sanjay Nandi from VT Capital.
Unknown Attendee
attendee[Foreign Language]
Manish Grover
executive[Foreign Language]
Operator
operatorThe next question is from the line of Akhilesh Rawat from [ Vedant ] Vision Private Limited.
Unknown Attendee
attendee[Foreign Language] Am I audible?
Manish Grover
executive[Foreign Language]
Unknown Attendee
attendee[Foreign Language]
Manish Grover
executive[Foreign Language]
Unknown Attendee
attendee[Foreign Language]
Manish Grover
executive[Foreign Language]
Unknown Attendee
attendee[Foreign Language] we will go to our other part of the...
Manish Grover
executive[Foreign Language]
Operator
operatorThe next question is from the line of Chirag Shah from White Pine Investment Management.
Chirag Shah
analyst[Foreign Language]
Manish Grover
executive[Foreign Language]
Chirag Shah
analyst[Foreign Language]
Manish Grover
executive[Foreign Language]
Chirag Shah
analyst[Foreign Language]
Manish Grover
executive[Foreign Language]
Chirag Shah
analyst[Technical Difficulty]
Manish Grover
executive[Foreign Language]
Operator
operatorThe next question is from the line of [indiscernible] Power.
Unknown Attendee
attendee[Foreign Language] increase our sale through e-commerce...
Manish Grover
executive[Foreign Language]
Unknown Attendee
attendee[Foreign Language] regarding quick commerce like Blinkit...
Manish Grover
executive[Foreign Language] Zepto, Blinkit [Foreign Language]
Unknown Attendee
attendee[Foreign Language] regarding healthcare Ease or South [Foreign Language]
Operator
operatorThe next question is from the line of Akshay from AK Investment.
Akshay Kaila
analyst[Foreign Language]
Manish Grover
executive[Foreign Language]
Operator
operatorLadies and gentlemen, that was the last question for today. I would now like to hand the conference over to the management for closing comments.
Manish Grover
executive[Foreign Language]
Operator
operatorNo, sir. It is like handed over to you for closing comments.
Manish Grover
executiveOkay. Okay. [Foreign Language]
Operator
operatorThank you. On behalf of Nuvama Wealth and Investment Limited, that concludes this conference. Thank you for joining us, and you may now disconnect your lines.
Read the full transcript via the API
You're viewing the first half of this call. Get the complete Jeena Sikho Lifecare Limited transcript — plus 256,000+ transcripts from 12,000+ companies, speaker segments, AI summaries and full-text search — through the EarningsCalls.dev API.
Get the API View API docs →For developers and AI pipelines
Programmatic access to Jeena Sikho Lifecare Limited earnings transcripts and 256,000+ others is available through the
EarningsCalls.dev REST API. Plans from $24.99/month — full transcripts, speaker segments,
full-text search, and the recently-added /api/v1/transcripts/recent polling endpoint for ETL pipelines.
More tools for stock research
OptionsBell: an unusual options activity scanner that tracks options flow across all US stocks and emails you when large trades appear in Jeena Sikho Lifecare Limited or any ticker on your watchlist.
StockMarketScan: a stock screener with alerts: 24 pre-built screens refreshed every 5 minutes, watchlists and email notifications. Both offer API and MCP access and fair monthly pricing.